{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:06:58Z","timestamp":1789668418561,"version":"4.0.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Objective<\/jats:title>\n<jats:p>To determine the time to resolution of tubal ectopic pregnancy after methotrexate treatment.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A 14-year retrospective cohort study was performed from 2004\u20132018 and assessed 216 women treated with single-dose methotrexate for tubal ectopic pregnancy. Women were treated using a single-dose protocol of intramuscular methotrexate (50mg\/m<jats:sup>2<\/jats:sup>) for confirmed tubal ectopic pregnancy on ultrasound. Ectopic pregnancies were included if the ectopic pregnancy mass was &lt;35mm, no evidence of rupture and no embryonic cardiac activity. Serum hCG was measured on day 1, 4 and 7 of treatment and then at standard weekly intervals until resolution. Where there was not a \u226515% decline in hCG from day 4 and day 7, a second dose of methotrexate was administered. The primary outcome was time to resolution (days), with serum hCG &lt;5 IU\/L considered resolved. The secondary outcome was need for rescue surgery.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Among women who did not proceed to surgery, the median time to resolution was 22 days (IQR 14,34). Time to resolution and need for rescue surgery increased with baseline hCG. When hCG was &lt;1000 IU\/L, the median was 20 days (IQR 13,29) but 34.5 days (IQR 22,48) with hCG &gt;2000 IU\/L. Early hCG trends were predictive of time to resolution and likelihood of rescue surgery; a hCG rise of &gt;1000 IU\/L between Days 1\u20134 increased time to resolution to 61 days (IQR 35,80) and an odds ratio of rescue surgery of 28.6 (95% C.I. 5.3,155.4).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The median time to resolution for ectopic pregnancies treated with methotrexate is 22 days and associated with baseline hCG levels. The predictive value of baseline hCG may be useful in clinical decision making and counselling women considering methotrexate for ectopic pregnancy.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0268741","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T17:38:24Z","timestamp":1653413904000},"page":"e0268741","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Time to resolution of tubal ectopic pregnancy following methotrexate treatment: A retrospective cohort study"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3437-126X","authenticated-orcid":true,"given":"Marcus J.","family":"Davenport","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthea","family":"Lindquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Brownfoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7388-2193","authenticated-orcid":true,"given":"Natasha","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne","family":"Hastie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"issue":"4","key":"pone.0268741.ref001","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1021106032198","article-title":"Surveillance in a time of changing health care practices: estimating ectopic pregnancy incidence in the United States","volume":"6","author":"SB Zane","year":"2002","journal-title":"Matern Child Health J"},{"issue":"4","key":"pone.0268741.ref002","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/AOG.0b013e3182113c10","article-title":"Trends in ectopic pregnancy mortality in the United States: 1980\u20132007","volume":"117","author":"AA Creanga","year":"2011","journal-title":"Obstet Gynecol."},{"issue":"12","key":"pone.0268741.ref003","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1093\/humrep\/17.12.3224","article-title":"Sites of ectopic pregnancy: a 10 year population-based study of 1800 cases","volume":"17","author":"J Bouyer","year":"2002","journal-title":"Hum Reprod"},{"issue":"5","key":"pone.0268741.ref004","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.fertnstert.2018.05.020","article-title":"Primary hepatic pregnancy: report of a case treated with laparoscopic approach and review of the literature","volume":"110","author":"S Garzon","year":"2018","journal-title":"Fertil Steril"},{"issue":"6","key":"pone.0268741.ref005","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0015-0282(16)46349-1","article-title":"Treatment of interstitial ectopic pregnancy with methotrexate: report of a successful case","volume":"37","author":"T Tanaka","year":"1982","journal-title":"Fertil Steril"},{"issue":"4","key":"pone.0268741.ref006","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humupd\/dmn012","article-title":"Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis","volume":"14","author":"F Mol","year":"2008","journal-title":"Hum Reprod Update"},{"issue":"3","key":"pone.0268741.ref007","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/AOG.0000000000002559","article-title":"ACOG Practice Bulletin No. 193 Summary: Tubal Ectopic Pregnancy","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"3","key":"pone.0268741.ref008","first-page":"406","article-title":"Serial endovaginal sonography of ectopic pregnancies treated with methotrexate","volume":"77","author":"DL Brown","year":"1991","journal-title":"Obstet Gynecol"},{"issue":"10","key":"pone.0268741.ref009","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/humrep\/17.10.2585","article-title":"The ultrasonographic appearance of tubal pregnancy in patients treated with methotrexate","volume":"17","author":"R Gamzu","year":"2002","journal-title":"Hum Reprod"},{"issue":"3","key":"pone.0268741.ref010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.fertnstert.2006.10.007","article-title":"Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review","volume":"87","author":"S Menon","year":"2007","journal-title":"Fertil Steril"},{"issue":"13","key":"pone.0268741.ref011","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/j.1471-0528.2011.03133.x","article-title":"Decline in betahCG levels between days 0 and 4 after a single dose of methotrexate for ectopic pregnancy predicts treatment success: a retrospective cohort study","volume":"118","author":"MM Skubisz","year":"2011","journal-title":"BJOG"},{"key":"pone.0268741.ref012","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2393-13-30","article-title":"Using a decline in serum hCG between days 0\u20134 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study","volume":"13","author":"M Skubisz","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"issue":"6","key":"pone.0268741.ref013","doi-asserted-by":"crossref","first-page":"630.e1","DOI":"10.1016\/j.ajog.2010.03.022","article-title":"Are early human chorionic gonadotropin levels after methotrexate therapy a predictor of response in ectopic pregnancy?","volume":"202","author":"Q Nguyen","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"pone.0268741.ref014","first-page":"754","article-title":"Single-dose methotrexate for treatment of ectopic pregnancy","volume":"77","author":"TG Stovall","year":"1991","journal-title":"Obstet Gynecol"},{"issue":"6","key":"pone.0268741.ref015","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/0002-9378(93)90687-E","article-title":"Single-dose methotrexate: an expanded clinical trial","volume":"168","author":"TG Stovall","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"pone.0268741.ref016","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9378(96)70219-3","article-title":"Single-dose methotrexate for the treatment of ectopic pregnancy: Northwestern Memorial Hospital three-year experience","volume":"174","author":"CS Stika","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"pone.0268741.ref017","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0015-0282(16)56994-5","article-title":"Efficacy and safety of single-dose systemic methotrexate in the treatment of ectopic pregnancy","volume":"62","author":"JL Glock","year":"1994","journal-title":"Fertil Steril"},{"issue":"3","key":"pone.0268741.ref018","first-page":"223","article-title":"Time length of negativization of hCG serum values after either surgical or medical treatment of ectopic pregnancy","volume":"40","author":"N Colacurci","year":"1998","journal-title":"Panminerva Med."},{"issue":"4","key":"pone.0268741.ref019","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00404-003-0543-4","article-title":"Single-dose methotrexate for the treatment of unruptured ectopic pregnancy","volume":"270","author":"M Erdem","year":"2004","journal-title":"Arch Gynecol Obstet"},{"key":"pone.0268741.ref020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejogrb.2016.11.016","article-title":"Predictive factors for the methotrexate treatment outcome in ectopic pregnancy: A comparative study of 400 cases","volume":"208","author":"L Bonin","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"2","key":"pone.0268741.ref021","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0020-7292(99)00114-9","article-title":"Predictive score for the systemic treatment of unruptured ectopic pregnancy with a single dose of methotrexate","volume":"67","author":"JJ Elito","year":"1999","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"pone.0268741.ref022","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0301-2115(01)00480-8","article-title":"Human chorionic gonadotropin patterns after a single dose of methotrexate for ectopic pregnancy.","volume":"100","author":"A Natale","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"pone.0268741.ref023","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejogrb.2004.04.017","article-title":"Pre- and post-treatment patterns of human chorionic gonadotropin for early detection of persistence after a single dose of methotrexate for ectopic pregnancy","volume":"117","author":"A Natale","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"pone.0268741.ref024","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5152\/jtgga.2013.50133","article-title":"Assessment of early decline in the percentage of beta-hCG values between days 0 and 4 after methotrexate therapy in ectopic pregnancy for the prediction of treatment success.","volume":"14","author":"E Celik","year":"2013","journal-title":"J Turk Ger Gynecol Assoc"},{"issue":"1","key":"pone.0268741.ref025","first-page":"3","article-title":"Prognostic value of early hCG changes after methotrexate injection for ectopic pregnancy","volume":"42","author":"P Bottin","year":"2014","journal-title":"Gynecol Obstet Fertil"},{"key":"pone.0268741.ref026","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejogrb.2016.10.022","article-title":"Methotrexate-treated ectopic pregnancy: beta human chorionic gonadotropin serum changes as a success predictor using a mathematical model validation.","volume":"210","author":"A Kovaleva","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"pone.0268741.ref027","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejogrb.2017.06.020","article-title":"Role of day 4 HCG as an early predictor of success after methotrexate therapy for ectopic pregnancies","volume":"215","author":"S Girija","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"pone.0268741.ref028","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ijgo.12419","article-title":"Trends in serum human chorionic gonadotropin levels 0\u20134 days after methotrexate administration for predicting tubal ectopic pregnancy treatment success","volume":"141","author":"L Wong","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"pone.0268741.ref029","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/uog.17329","article-title":"Single-dose systemic methotrexate vs expectant management for treatment of tubal ectopic pregnancy: a placebo-controlled randomized trial","volume":"49","author":"D Jurkovic","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"pone.0268741.ref030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1074-3804(05)81012-6","article-title":"Systemic treatment of ectopic pregnancies with single-dose methotrexate","volume":"1","author":"D Schafer","year":"1994","journal-title":"J Am Assoc Gynecol Laparosc"},{"issue":"3","key":"pone.0268741.ref031","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0020-7292(98)00038-1","article-title":"Single-dose methotrexate for unruptured ectopic pregnancy","volume":"61","author":"F Lecuru","year":"1998","journal-title":"Int J Gynaecol Obstet."},{"issue":"6","key":"pone.0268741.ref032","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0002-9378(98)70343-6","article-title":"Analysis of three hundred fifteen ectopic pregnancies treated with single-dose methotrexate","volume":"178","author":"GH Lipscomb","year":"1998","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"pone.0268741.ref033","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2004.12.061","article-title":"Comparison of multidose and single-dose methotrexate protocols for the treatment of ectopic pregnancy","volume":"192","author":"GH Lipscomb","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"pone.0268741.ref034","first-page":"192","article-title":"A randomised trial comparing single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured tubal pregnancy","volume":"108","author":"MC Sowter","year":"2001","journal-title":"BJOG"},{"issue":"2","key":"pone.0268741.ref035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ajog.2019.01.002","article-title":"Two-dose versus single-dose methotrexate for treatment of ectopic pregnancy: a meta-analysis.","volume":"221","author":"S Alur-Gupta","year":"2019","journal-title":"Am J Obstet Gynecol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0268741","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T17:39:01Z","timestamp":1653413941000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0268741"}},"subtitle":[],"editor":[{"given":"Simone","family":"Garzon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0268741","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,24]]}}}